Progress and potential of non-inhibitory small molecule chaperones for the treatment of Gaucher disease and its implications for Parkinson disease. - Wikidata - wikimedia - TriplyDB

Progress and potential of non-inhibitory small molecule chaperones for the treatment of Gaucher disease and its implications for Parkinson disease.

Progress and potential of non-inhibitory small molecule chaperones for the treatment of Gaucher disease and its implications for Parkinson disease.

http://www.wikidata.org/entity/Q37738863

about

Induced pluripotent stem cell models of lysosomal storage disorders.Chaperoning glucocerebrosidase: a therapeutic strategy for both Gaucher disease and Parkinsonism Progranulin Recruits HSP70 to β-Glucocerebrosidase and Is Therapeutic Against Gaucher Disease.Gaucher disease: Progress and ongoing challenges.The Complicated Relationship between Gaucher Disease and Parkinsonism: Insights from a Rare Disease.Stabilization of Glucocerebrosidase by Active Site Occupancy.The Spectrum of Neurological Manifestations Associated with Gaucher Disease.Pharmacoperones as Novel Therapeutics for Diverse Protein Conformational Diseases.Dysregulation of the autophagic-lysosomal pathway in Gaucher and Parkinson's disease.Reduced glucocerebrosidase activity in monocytes from patients with Parkinson's disease

P2860

Q33830512-3B16E204-B191-4291-8807-3A03B089D2B7 Q37548335-05908770-6C56-4704-9A30-5E30873AA3BD Q37604580-084B90B3-8C4A-48E5-BBAA-FE036D2FB314 Q39028972-15B1A4DE-4177-480F-B0A9-246C6C42C9C5 Q39148146-1788FB8F-7DDC-4F90-B8F8-A92BDC39935E Q41110570-A79337BF-DAD0-4538-9367-EE784F0A3F4A Q42136746-EC89E522-4F90-4F92-88BF-D1B5633AFEB4 Q50014672-24567DB2-C0FE-4CC9-8DEF-4D88EE81CE4A Q52689754-98B0CC03-4FE9-4743-B3A3-B4DBA8D8F137 Q58603525-2989B505-C815-42E6-BCA1-A4DE2D48C8A0

P2860

Progress and potential of non-inhibitory small molecule chaperones for the treatment of Gaucher disease and its implications for Parkinson disease.

http://www.wikidata.org/entity/Q37738863

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 April 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Progress and potential of non- ...... cations for Parkinson disease.

@en

Progress and potential of non- ...... cations for Parkinson disease.

@nl

type

label

Progress and potential of non- ...... cations for Parkinson disease.

@en

Progress and potential of non- ...... cations for Parkinson disease.

@nl

prefLabel

Progress and potential of non- ...... cations for Parkinson disease.

@en

Progress and potential of non- ...... cations for Parkinson disease.

@nl

P1433

Q37738863-D100CE38-82CD-4B50-901F-2F669FCF874D

P1476

Q37738863-9B7A65E0-D47B-41AD-8C43-8315A5B2EA44

P2093

Q37738863-026F1441-A57F-4A45-89A8-B6C7B185E3A9

Q37738863-2C06EB99-DCF3-40AF-B0AF-C2F98173689C

Q37738863-3C612D0A-5F86-4A11-A6D0-0B37C90AA8E4

Q37738863-77B52492-A258-4B94-A829-7B113C6F9FC2

Q37738863-CA07EE25-118C-4245-A27C-DEEB05F4E2A4

P2860

Q37738863-01A33DD9-5B4C-4300-9B5E-766739CB0167

Q37738863-03034D56-81A7-40D7-A428-6F60B2BB7F68

Q37738863-05748A8A-1257-4E15-84D0-3BF0AE47A9BC

Q37738863-0701FCB9-32C2-40E3-B17F-8F734EEB52D9

Q37738863-08BCBEB9-E6A0-4592-B41E-CEEA3C00BA12

Q37738863-0D3B014A-3B13-48E4-BEE9-767CE7A9D923

Q37738863-12ADFF8C-D637-459E-8C4C-4C1CFBD07357

Q37738863-13BDB3FE-5071-440D-AA2E-C896623D219C

Q37738863-1A6408EE-FADA-4C7C-9D6D-CE394C2CF9ED

Q37738863-1A9FD8BE-5F0F-476C-8C7B-9D03A2F487BA

P304

Q37738863-A3918AD8-3E36-4C90-B2B6-41BB6534FA08

P31

Q37738863-FE2518E9-B4E3-415C-A593-7715315CF17E

P356

Q37738863-AB962C43-AAF8-4E66-93F3-39CED79CBD4B

P433

Q37738863-E2333BBD-967C-4E29-ABE0-CADB3A73D9C0

P478

Q37738863-944B76DD-FC7D-4CF3-BFFD-23708F3149C7

P577

Q37738863-6545B656-93D5-46F1-8322-F7A7782DEF9A

P698

Q37738863-D4DCA291-0A42-49C5-892C-271B32D55517

P921

Q37738863-AA0FD32E-2F58-4F33-ACB9-82AF0E42DFC4

Q37738863-C5004470-EBDF-4DF1-9683-C44CD9EC81F9

P932

Q37738863-8E3D9E61-8110-40B1-9F44-BE69A408833F

P356

14789450.2016.1174583

P1433

Expert Review of Proteomics

P1476

Progress and potential of non- ...... cations for Parkinson disease.

@en

P2093

Ellen Sidransky

http://www.w3.org/2001/XMLSchema#string

Juan Marugan

http://www.w3.org/2001/XMLSchema#string

Olive Jung

http://www.w3.org/2001/XMLSchema#string

Samarjit Patnaik

http://www.w3.org/2001/XMLSchema#string

Wendy Westbroek

http://www.w3.org/2001/XMLSchema#string

P2860

Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies

Glucocerebrosidase is shaking up the synucleinopathies

A gene network regulating lysosomal biogenesis and function

Chaperone-mediated autophagy: a unique way to enter the lysosome world

Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.

Recommendations for the use of eliglustat in the treatment of adults with Gaucher disease type 1 in the United States

Eliglustat tartrate for the treatment of adults with type 1 Gaucher disease

Structure of acid beta-glucosidase with pharmacological chaperone provides insight into Gaucher disease

Autophagy fights disease through cellular self-digestion

Glucocerebrosidase mutations in subjects with parkinsonism

P304

471-479

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14789450.2016.1174583

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27098312

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

molecular chaperones

P932

5381920

http://www.w3.org/2001/XMLSchema#string